- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01759368
Heart at Home- a Self-care Study
September 15, 2014 updated by: VTT Technical Research Centre of Finland
Heart at Home- Remote Patient Monitoring in the Care of Heart Failure Patients
In the study benefits of using mobile phone assisted remote patient monitoring including self-measurements of blood pressure, heart rate and weight as well as monitoring of personal health status are investigated in the care of heart failure patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
94
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Espoo, Finland
- VTT Technical Research Centre of Finland
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- diagnosis of systolic heart failure
- NYHA (New York Heart Association) classification > 1
- left ventricular ejection fraction ≤ 35%
- need for a regular control visit
- time from the last visit no longer than 6 months
Exclusion Criteria:
- Patients who were known to enter a major medical operation
- severe comorbidity,
- participation in other clinical trial during last three months-
- poor compliance in terms of familiarity with mobile phone
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Telemonitoring assisted self-care
Telemonitoring group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions.
The measurements taken at home to be uploaded were: diastolic and systolic blood pressure, pulse, body weight and an assessment of symptoms.
The symptom assessment concerned the patient's feelings of dizziness, dyspnea, palpitation, weakness and, oedema.
Patients were also asked to evaluate their overall condition- whether their condition had deteriorated, improved or remained unchanged.
The patients were advised to carry out and report the measurements together with the self-assessment once a week.
The responsible nurse followed patients' status and the data once a week or more frequently if needed.
Based on the reported measurements, the nurse could invite the patient for a control visit.
In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring.
|
Telemonitoring group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions.
The measurements taken at home to be uploaded were: diastolic and systolic blood pressure, pulse, body weight and an assessment of symptoms.
The symptom assessment concerned the patient's feelings of dizziness, dyspnea, palpitation, weakness and, oedema.
Patients were also asked to evaluate their overall condition- whether their condition had deteriorated, improved or remained unchanged.
The patients were advised to carry out and report the measurements together with the self-assessment once a week.
The responsible nurse followed patients' status and the data once a week or more frequently if needed.
Based on the reported measurements, the nurse could invite the patient for a control visit.
In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring
|
No Intervention: Control group
Control group received usual care that includes multidisciplinary care approach in which patients receive guidance and support for self-care.
In the care of heart failure (HF) patients, the cardiac team plays a central role in monitoring and interpreting patient symptoms, optimizing medication and providing education.
The cardiac team consists of two physicians, one specialized heart failure nurse and a physiotherapist who helps after a hospitalization period.
As part of the care process, patients capable of carrying out self-care are identified and they are encouraged to regularly measure their blood pressure, heart rate and weight at home.
So far, the information exchange between heart failure patients and care personnel has taken place during patients' visits to the clinic and by telephone.
Systematic collection and exploitation of the self-measurement data has been difficult, since it depends on the patient's own activity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of HF-related Hospital Days
Time Frame: From baseline until the end of the study at six months
|
Number of heart failure related hospital days
|
From baseline until the end of the study at six months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Death
Time Frame: From baseline until the end of the study at six months
|
Death from any cause
|
From baseline until the end of the study at six months
|
Heart Transplant
Time Frame: From baseline until the end of the study at six months
|
Heart transplant operation or listing for transplant operation
|
From baseline until the end of the study at six months
|
P-proBNP
Time Frame: From baseline until the end of the study at six months
|
Change in plasma concentration of brain natriuretic peptide propeptide from baseline to the end of the study.
|
From baseline until the end of the study at six months
|
EHFSBS (European Heart Failure Self-Care Behaviour Scale ) Scores
Time Frame: From baseline until the end of the study at six months
|
Change in self-care behaviour measured by the European Heart Failure Self-Care Behaviour Scale (EHFSBS).
EHFSBS is a 12-item self-administered questionnaire specifically designed and tested for heart failure patients including statements on self-care behaviour essential in the care of HF.
The statements are scored from one to five.
The lower the score, the better the performance in self-care.
The summary score is analysed.
|
From baseline until the end of the study at six months
|
Left Ventricular Ejection Fraction
Time Frame: From baseline until the end of the study at six months
|
Change in left ventricular ejection fraction from baseline until the end of the study
|
From baseline until the end of the study at six months
|
Utilization of Health Care Resources
Time Frame: From baseline until the end of the study at six months
|
Number of visits to nurse's reception
|
From baseline until the end of the study at six months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Plasma Concentrations of Creatinine, Natrium, and Potassium From the Baseline to the End of the Study
Time Frame: From baseline to the end of the study at six months
|
Change in plasma concentrations of creatinine, natrium, and potassium
|
From baseline to the end of the study at six months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
June 1, 2012
Study Registration Dates
First Submitted
December 20, 2012
First Submitted That Met QC Criteria
December 30, 2012
First Posted (Estimate)
January 3, 2013
Study Record Updates
Last Update Posted (Estimate)
September 17, 2014
Last Update Submitted That Met QC Criteria
September 15, 2014
Last Verified
September 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUSHAH
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
US Department of Veterans AffairsCompleted
Clinical Trials on Telemonitoring assisted self-care
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType 2 Diabetes MellitusUnited States
-
Chang Hee, LeePurdue University; LG Electronics Inc.CompletedHypertensionKorea, Republic of
-
ResMedCompleted
-
Chang Hee, LeePurdue University; LG Electronics Inc.CompletedObesity | Metabolic SyndromeKorea, Republic of
-
Universidad de la RepublicaHospital Italiano de Buenos Aires; KU LeuvenWithdrawn
-
Institute of Liver and Biliary Sciences, IndiaCompleted
-
University of MichiganCompletedPost-dischargeUnited States
-
University of MichiganCompletedPost-dischargeUnited States
-
University Hospital, ToulouseCompleted
-
Georg Nilius, Prof DR medHeinen und Löwenstein GmbH & Co. KGRecruitingChronic Obstructive Pulmonary DiseaseGermany